Skip to main content
Top
Gepubliceerd in: Tijdschrift voor Kindergeneeskunde 4/2006

01-08-2006 | Artikelen

Nieuwe ontwikkelingen in de behandeling van het kortedarmsyndroom bij kinderen

Dieet en hormoontherapie

Auteurs: Dr. J. A. J. M. Taminiau, D. Tibboel, E. H. H. M. Rings

Gepubliceerd in: Tijdschrift voor Kindergeneeskunde | Uitgave 4/2006

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Samenvatting

Het kortedarmsyndroom wordt veroorzaakt door malabsorptie van macronutriënten, vitaminen en spoorelementen en gaat gepaard met gewichtsverlies. Kinderen met deze aandoening zijn vaak afhankelijk van parenterale voeding, hetgeen weer risico geeft op levensbedreigende complicaties. Aanpassingen in het dieet, maar ook hormoontherapie gericht op de adaptatie van het epitheel, zouden de opnamecapaciteit van de darm kunnen verbeteren, en daarmee afhankelijkheid van parenterale voeding kunnen voorkomen.
Literatuur
go back to reference Messing B, Pigot F, Rongier M, et al. Intestinal absorption of free oral hyperalimentation in the very short bowel syndrome. Gastroenterology 1991;100:1502-8.PubMed Messing B, Pigot F, Rongier M, et al. Intestinal absorption of free oral hyperalimentation in the very short bowel syndrome. Gastroenterology 1991;100:1502-8.PubMed
go back to reference Jeppeson PB, Mortensen PW. Experimental approaches: dietary and hormone therapy. Best Pract Res Clin Gastroenterol 2003;17:1041-54.CrossRef Jeppeson PB, Mortensen PW. Experimental approaches: dietary and hormone therapy. Best Pract Res Clin Gastroenterol 2003;17:1041-54.CrossRef
go back to reference Norgard DI, Hansen BS, Mortensen PB. Importance of colonic support for energy absorption as small bowel failure proceeds. Am J Clin Nutr 1996;64:222-31. Norgard DI, Hansen BS, Mortensen PB. Importance of colonic support for energy absorption as small bowel failure proceeds. Am J Clin Nutr 1996;64:222-31.
go back to reference Jeppesen PB, Mortensen PB. The influence of a preserved colon on the absorption of medium chain fat in patients with small bowel resection. Gut 1998;43:478-83.PubMedCrossRef Jeppesen PB, Mortensen PB. The influence of a preserved colon on the absorption of medium chain fat in patients with small bowel resection. Gut 1998;43:478-83.PubMedCrossRef
go back to reference Bohane TD, Haka-Ikse K, Biggar WD, et al. A clinical study of young infants after small intestinal resection. J Pediatr 1979;94:552-8.CrossRefPubMed Bohane TD, Haka-Ikse K, Biggar WD, et al. A clinical study of young infants after small intestinal resection. J Pediatr 1979;94:552-8.CrossRefPubMed
go back to reference Briet F, Flourié B, Achour L, et al. Bacterial adaptation in patients with short bowel and colon in continuity. Gastroenterology 1995;109:1446-53.CrossRefPubMed Briet F, Flourié B, Achour L, et al. Bacterial adaptation in patients with short bowel and colon in continuity. Gastroenterology 1995;109:1446-53.CrossRefPubMed
go back to reference Marteau P, Messing B, Arrigoni E, et al. Do patients with short-bowel syndrome need a lactose-free diet? Nutrition 1997;13:13-6.CrossRefPubMed Marteau P, Messing B, Arrigoni E, et al. Do patients with short-bowel syndrome need a lactose-free diet? Nutrition 1997;13:13-6.CrossRefPubMed
go back to reference Lifschitz CH. Growth hormone for short bowel adaptation: is less more effective than more? [editorial]. J Pediatr Gastroenterol Nutr 2004;38(1):111-2.CrossRefPubMed Lifschitz CH. Growth hormone for short bowel adaptation: is less more effective than more? [editorial]. J Pediatr Gastroenterol Nutr 2004;38(1):111-2.CrossRefPubMed
go back to reference Jeppesen PB, Sanuinetti EL, Buchman A, et al. Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients. Gut 2005;54(9):1224-31.CrossRefPubMed Jeppesen PB, Sanuinetti EL, Buchman A, et al. Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients. Gut 2005;54(9):1224-31.CrossRefPubMed
go back to reference Severijnen RSVM, Swieten ECAM van, Tolboom JJM, et al. Contribution of growth hormone treatment in children with a short small bowel [thesis]. Short small bowel in children. 2004. Severijnen RSVM, Swieten ECAM van, Tolboom JJM, et al. Contribution of growth hormone treatment in children with a short small bowel [thesis]. Short small bowel in children. 2004.
go back to reference Byrne TA, Wilmore DW, Iyer K, et al. Growth hormone, glutamine, and an optimal diet reduces parenteral nutrition in patients with short bowel syndrome: a prospective, randomized, placebo-controlled, double-blind clinical trial. Ann Surg 2005;242 (5):655-61.CrossRefPubMed Byrne TA, Wilmore DW, Iyer K, et al. Growth hormone, glutamine, and an optimal diet reduces parenteral nutrition in patients with short bowel syndrome: a prospective, randomized, placebo-controlled, double-blind clinical trial. Ann Surg 2005;242 (5):655-61.CrossRefPubMed
go back to reference Lifschitz C, Dugan C, Langston C, et al. Growth hormone therapy in children with short bowel syndrome: a randomized placebo-controlled trial. Gastroenterology 2003;124:A64.CrossRef Lifschitz C, Dugan C, Langston C, et al. Growth hormone therapy in children with short bowel syndrome: a randomized placebo-controlled trial. Gastroenterology 2003;124:A64.CrossRef
go back to reference Nucci AM, Finegold DN, Yaworski JA, et al. Results of growth trophic therapy in children with short bowel syndrome. J Pediatr Surg 2004;39(3):335-9.CrossRefPubMed Nucci AM, Finegold DN, Yaworski JA, et al. Results of growth trophic therapy in children with short bowel syndrome. J Pediatr Surg 2004;39(3):335-9.CrossRefPubMed
go back to reference Sigalet DL, Martin G, Meddings J, et al. GLP-2 levels in infants with intestinal dysfunction. Pediatr Res 2004;56(3):371-6.CrossRefPubMed Sigalet DL, Martin G, Meddings J, et al. GLP-2 levels in infants with intestinal dysfunction. Pediatr Res 2004;56(3):371-6.CrossRefPubMed
go back to reference Weiming Z, Ning L, Jieshou L. Effect of recombinant human growth hormone and enteral nutrition on short bowel sundrome. JPEN J Parenter Enteral Nutr 2004;28(6):377-81.CrossRefPubMed Weiming Z, Ning L, Jieshou L. Effect of recombinant human growth hormone and enteral nutrition on short bowel sundrome. JPEN J Parenter Enteral Nutr 2004;28(6):377-81.CrossRefPubMed
Metagegevens
Titel
Nieuwe ontwikkelingen in de behandeling van het kortedarmsyndroom bij kinderen
Dieet en hormoontherapie
Auteurs
Dr. J. A. J. M. Taminiau
D. Tibboel
E. H. H. M. Rings
Publicatiedatum
01-08-2006
Uitgeverij
Bohn Stafleu van Loghum
Gepubliceerd in
Tijdschrift voor Kindergeneeskunde / Uitgave 4/2006
Print ISSN: 0376-7442
Elektronisch ISSN: 1875-6840
DOI
https://doi.org/10.1007/BF03061629

Andere artikelen Uitgave 4/2006

Tijdschrift voor Kindergeneeskunde 4/2006 Naar de uitgave

Boekbespreking

Boekbespreking